Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 23.23 M

Veracyte, Inc. Depreciation And Amortization is USD 23.23 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -11.02% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 26.11 M, a 0.25% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 26.04 M, a 10.35% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 23.60 M, a 176.92% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 8.52 M, a 65.67% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased